Page last updated: 2024-08-23

paclitaxel and Cryptogenic Fibrosing Alveolitis

paclitaxel has been researched along with Cryptogenic Fibrosing Alveolitis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Ando, M; Atagi, S; Harada, T; Hayashi, H; Horinouchi, H; Ichihara, E; Ichikado, K; Ikeda, S; Kato, T; Kenmotsu, H; Kimura, Y; Kishimoto, J; Kondo, M; Kondoh, Y; Kusumoto, M; Minegishi, Y; Nakagawa, K; Nakanishi, Y; Nakatomi, K; Okamoto, I; Otsubo, K; Takemoto, S; Tamiya, M; Yamamoto, N	1
Ando, M; Atagi, S; Horinouchi, H; Ichihara, E; Ichikado, K; Kato, T; Kenmotsu, H; Kishimoto, J; Kondoh, Y; Kusumoto, M; Minegishi, Y; Nakanishi, Y; Okamoto, I; Otsubo, K; Shiraki, A; Yamamoto, N	1
Morio, A	1

Trials

2 trial(s) available for paclitaxel and Cryptogenic Fibrosing Alveolitis

Article	Year
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial. The European respiratory journal, 2022, Volume: 60, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Paclitaxel	2022
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis. Clinical lung cancer, 2018, Volume: 19, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Analysis; Young Adult	2018

Article

Year

Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.

The European respiratory journal, 2022, Volume: 60, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Paclitaxel

2022

Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.

Clinical lung cancer, 2018, Volume: 19, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Analysis; Young Adult

2018

Other Studies

1 other study(ies) available for paclitaxel and Cryptogenic Fibrosing Alveolitis

Article	Year
[A Case of Advanced Lung Squamous Cell Carcinoma with Idiopathic Pulmonary Fibrosis Treated with Salvage Surgery and Chemotherapy Using Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:8 Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Paclitaxel; Salvage Therapy	2018

Article

Year

[A Case of Advanced Lung Squamous Cell Carcinoma with Idiopathic Pulmonary Fibrosis Treated with Salvage Surgery and Chemotherapy Using Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel].

Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:8

Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Male; Paclitaxel; Salvage Therapy

2018